Top Ten most popular articles on Pharmafile.com this week
August 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten
Eight months of 2018 down – where has the year gone? As we move from August into September, and a …
DIA’s Global Clinical Trials Transparency Conference & Clinical Trials Regulations Conference
August 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Disclosure and transparency of clinical trial information is taking on new dimensions in the EU and US. Moreover, while the …
Global orphan and rare dermatology market set to exceed $6 billion by 2024
August 31, 2018Medical Communications Orphan Drugs, analysis, dermatology, market reports, rare diseases
The global orphan and rare dermatology premium products market is expected to grow rapidly in the next half a decade …
Shire hands over its oncology franchise to Servier for $2.4bn
August 31, 2018Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale
Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …
Trump administration resists WHO efforts to tackle antimicrobial resistance
August 31, 2018Medical Communications AMR, Trump, US, US government, WHO, antimicrobial resistance
The Trump administration is in the process of drafting an alternative to the World Health Organization’s guidelines on the use …
AZ’s lupus drug fails to curb lupus activity at Phase 3
August 31, 2018Medical Communications, Research and Development AstraZeneca, Lupus, anifrolumab, pharma
AstraZeneca and its biologics R&D arm MedImmune have released a statement admitting that their fully human monoclonal antibody anifrolumab failed …
Bristol-Myers Squibb appoints Christopher Boerner as new Executive Vice President and Chief Commercial Officer
August 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, bristol myers squibb, cco, chief commercial officer, christopher boerner, executive vice president, murdo gordon
Bristol Myers Squibb has announced that Dr Christopher Boerner will take over from Murdo Gordon as executive Vice President and …
Contraceptive app Natural Cycles investigated over “misleading” efficacy claims
August 30, 2018Medical Communications, Sales and Marketing APP Pharma, Natural Cycles, UK, app. pharma
The company behind Natural Cycles, the first-ever approved smartphone app promising a natural alternative to contraception, has seen a Facebook …
Drug slows brain shrinkage associated with progressive multiple sclerosis, study shows
August 30, 2018Research and Development MS, brain, ibudilast, neuroscience, research
The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …
CBD dampens activity in brain regions associated with psychosis, study shows
August 30, 2018Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study
Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its …
AstraZeneca’s once-weekly auto-injector Bydureon BCise wins EU approval in type 2 diabetes
August 30, 2018Research and Development, Sales and Marketing AstraZeneca, Bydureon, EU, Europe, diabetes, pharma, type 2 diabetes
AstraZeneca has announced that its auto-injector Bydureon BCise (exenatide 2mg prolonged-release suspension) has been approved by the European Commission for …
Opioid prescriptions hit 15 year low, as FDA’s Gottlieb reaffirms commitment against crisis
August 30, 2018Medical Communications FDA, opioid crisis, prescriptions, scott gottleib
The amount of opioids prescribed to patients in the United States has fallen to a 15 year low according to …
Jazz Pharma’s acute myeloid leukaemia drug scores EU approval
August 29, 2018Research and Development, Sales and Marketing Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, leukaemia, pharma
Jazz Pharmaceuticals has revealed that its advanced liposomal formulation Vyxeos has received approval from the European Commission for the treatment …
Emergent snaps up Adapt and its opioid overdose therapy for $735m
August 29, 2018Research and Development, Sales and Marketing Emergent, Narcan, naloxone, opioid crisis, opioids, pharma
Emergent BioSolutions has announced it has signed an agreement to acquire Adapt Pharma at a valuation of $735 million, a …
NHS guidance suggests mental health therapists should be brought into GP surgeries
August 29, 2018Research and Development England, GP, NHS, guidance, psychology, psychotherapy
New NHS guidelines will encourage doctors to incorporate mental health therapists into practice surgeries in an effort to bring more …
FDA warns against King Bio products after company expands recall
August 29, 2018Research and Development Contamination, FDA, homeopathy, king bio, recall
The US Food and Drug Administration is warning consumers and pet owners not to use products that have been manufactured …
Novartis to create 450 new jobs at Aargau site after Kymriah thumbs up
August 29, 2018Research and Development CAR T, CAR-T, Jobs, Kymriah, Novartis
Swiss multinational Novartis is set to create up to 450 new jobs following the investment of 90 million Swiss Francs …
Eisai’s weight loss drug lorcaserin found safe in major study
August 28, 2018Manufacturing and Production, Research and Development, Sales and Marketing Eisai, lorcaserin, safety, study, weight loss
Eisai’s weight loss drug lorcaserin does not increase people’s risk of major cardiovascular events according to a study of 12,000 …
Ionis/Akcea’s ultra-rare disease drug rejected by FDA
August 28, 2018Manufacturing and Production, Sales and Marketing Akcea, FDA, Ionis, familial chylomicronemia syndrome, pharma, rare disease
The FDA has opted to refuse approval to Akcea and Ionis’ Waylivra (volanesorsen) for the treatment of the ultra-rare hereditary …
Researchers develop anti-nicotine addiction drugs
August 28, 2018Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university
Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
